Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

This study has been terminated.
(Lack of accrual)
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01532232
First received: February 9, 2012
Last updated: July 14, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)